News and Insights

What's New

Why health plans need to refresh their surgical implant strategy

Why health plans need to refresh their surgical implant strategy

Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital.

Evolent and Careology form strategic care navigation partnership

Evolent and Careology form strategic care navigation partnership

Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.

Read Press Release

The “dystopian” state of primary care

The “dystopian” state of primary care

Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care.

It's Cancer Prevention Month. Here are 11 ways to reduce your risk

It's Cancer Prevention Month. Here are 11 ways to reduce your risk.

Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more.

Read External Article

Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations.

Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more.

Read External Article

Medicare Drug Price Negotiations and Anticipated Ripple Effects

Medicare Drug Price Negotiations and Anticipated Ripple Effects

Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies.

Read External Article

Genetic Testing in Cancer Care

Genetic testing in cancer care: Considerations for a condition-based approach

Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care.

Read External Article

Evolent facilitates response to cancer drug shortages

Evolent facilitates response to cancer drug shortages

Evolent takes a multifaceted approach to help providers navigate shortages of cisplatin, carboplatin and other anti-cancer drugs.

Reducing Cancer Therapy’s Toll on the Heart

Reducing Cancer Therapy’s Toll on the Heart

Evolent is leveraging our expertise in two key specialties to reduce cardiovascular damage related to cancer drugs.

A 'Pink Tax' in Oncology

A 'Pink Tax' in Oncology?

Evolent addresses a startling difference in what men and women pay for the same drug.

When Less is More in Radiation Oncology

When Less is More in Radiation Oncology

An Evolent program reduces unnecessary radiation treatments for breast cancer without compromising efficacy.

How to Talk to Family Members About Hospice and End-of-Life Care

How to Talk to Family Members About Hospice and End-of-Life Care

Evolent's Connie Ducaine writes in MarketWatch that patients need to be proactive to ensure their preferences for end of life are respected.

Read External Article

Clinical Expertise When It Matters Most

Clinical Expertise When It Matters Most

Our evidence-driven, patient-first model helps produce more informed decisions.

Connecting Our Businesses. Connecting Care.

Connecting Our Businesses. Connecting Care.

Our solutions are coming together under one brand to improve outcomes for people with complex health conditions.

Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

Company's solutions are coming together to improve outcomes for people living with complex health conditions.

Read Press Release